Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer.
Journal: Future oncology (London, England)
Published: May 15, 2025
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 06, 2024
Showing 1-2 of 2
Last Updated: 09/26/2026